1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Lot-to-lot immunogenicity consistency of the respiratory syncytial virus prefusion F protein vaccine in older adults
(
- Contribution to journal › Article
- 2023
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
(
- Contribution to journal › Article
-
Mark
Health care use after severe respiratory tract infections in children aged 0 to 5 years
2023) In Scandinavian Journal of Public Health(
- Contribution to journal › Article
- 2016
-
Mark
Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season : A Swedish National Study
(
- Contribution to journal › Article
- 2006
-
Mark
U-EPX levels and wheezing in infants and young children with and without RSV bronchiolitis
(
- Contribution to journal › Article
-
Mark
Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-bissau
(
- Contribution to journal › Article
- 2005
-
Mark
Immunoglobulin heavy G2 chain (IGHG2) gene restriction in the development of severe respiratory syncytial virus infection
(
- Contribution to journal › Article